✦ LIBER ✦

Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)

✍ Scribed by Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisneros, N; Davila, E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second line weekly docetaxel in advanced

✍ Serke, M; Rücker, M; Schönfeld, N; Loddenkemper, R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 124 KB

O-1 A phase III trial comparing weekly a

✍ Schuette, Wolfgang; Nagel, Sylke; Lautenschlaeger, C.; Serke, Monika; Wollschlae 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

P-551 A phase II randomized trial of wee

✍ Tsai, Chun-Ming; Chiu, Chao-Hua; Wang, Gwo-Shu; Su, Wei-Juin; Chen, Yuh-Min; Per 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Phase I/II trial of gemcitabine plus doc

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

Weekly docetaxel as second line chemothe

✍ M. Serke; D. Argiropolus; N. Schönfeld; R. Loddenkemper 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Phase II trial of weekly docetaxel in se

✍ Rogerio C. Lilenbaum; Michael A. Schwartz; Leonard Seigel; Francisco Belette; Ar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

The authors thank Jim Herndon, Ph.D., for the statistical analysis and Ana Maria Gonzalez-Angulo, M.D., for article review and preparation.